AI is already changing how pharma marketers work, from summarizing research to analyzing campaign performance and identify ...

Novo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to ...

Roche’s T-cell engager portfolio has notched another milestone, as a phase 3 trial of the company’s Lunsumio met its primary ...

Sun Pharma is teaming up with fashion designer Christian Siriano for a new educational campaign focused on the positives of ...

Eli Lilly is marking World Alzheimer’s Day with a partnership to distribute 13,500 boxes of brain-healthy fresh produce and ...

Following the news that longtime helmsman Paul Chaplin would be hanging up his hat at Bavarian Nordic earlier this year, the ...

CEO Andrea Palmer has revealed her next post. | Former Publicis Health Media CEO Andrea Palmer has revealed her next post.

Fayuvi, previously known as UX111, uses an adeno-associated viral vector to deliver a working copy of the SGSH gene into the patient’s cells. It marks the first FDA-approved therapy designed to ...

Bayer just scored another label expansion for its blockbuster-in-waiting, Kerendia. | The heart and kidney med earned the first FDA nod in three decades for adults with chronic kidney disease ...

The FDA issued a warning letter to Bausch & Lomb over contamination concerns at its Tampa, Florida, facility that produces prescription and over-the-counter eye medications.

Acclaimed comedian, actor and writer Damon Wayans recently added patient advocate and spokesperson to his resume through a humor-forward Genentech campaign, “All Eyes on DME,” that raises awareness | ...

New phase 3 data show Vera Therapeutics’ Trutakna successfully stabilizes kidney function in IgA nephropathy patients, ...